Fundraising Fox

Eric B. Lev

Investor

General Partner at Ampersand

About

Eric B. Lev is a General Partner at Ampersand, which he joined in 2013, with more than 22 years of experience in middle-market healthcare investing. He was previously a founding member of the investment team at Water Street Healthcare Partners for seven years, and earlier worked at Beckman Coulter and One Equity Partners. He holds a B.A. in Economics from Northwestern University and an M.B.A. from the University of Chicago.

Invests in

BiotechHealthtech

Investments

Board seats

AIT BioscienceBiologosBiosynthCutisPharmaGenoptixiuvo BiosciencesLakePharmaNexcelom BiosciencesNuvinkaDxP95Resolian

Per the firm's website.

Colleagues at Ampersand

Frequently asked questions

Who is Eric B. Lev?
Eric B. Lev is a General Partner at Ampersand, which he joined in 2013, with more than 22 years of experience in middle-market healthcare investing. He was previously a founding member of the investment team at Water Street Healthcare Partners for seven years, and earlier worked at Beckman Coulter and One Equity Partners. He holds a B.A. in Economics from Northwestern University and an M.B.A. from the University of Chicago.
Where does Eric B. Lev work?
Eric B. Lev is General Partner at Ampersand.
What does Eric B. Lev invest in?
Eric B. Lev invests in Biotech, Healthtech.
What boards does Eric B. Lev sit on?
Eric B. Lev holds tracked board seats at AIT Bioscience, Biologos, Biosynth, CutisPharma, Genoptix, iuvo Biosciences, LakePharma, Nexcelom Biosciences, NuvinkaDx, P95.